RE:RE:RE:2021 Insider BuyingIt's a mixture of cash and options granted for free. Prior to the annual meeting I had suggested the same to them. The Chairwomen's reponse was that the options align them with shareholders. In my book, unless you've paid for your ownership and put your own skin-in-the-game, it's a very mild form of alignment. Management is different, but for Boards, it is often seen as free icing on the cake --I paid nothing and may get a windfall without risking one penny of my own. So I disageed with her and PL on that. None of them are at the point in their careers where they are desperately in need of all the cash they are paid, if any. Many firms strongly urge their boards to use some of that to buy shares when allowed. Insider buying has been extremely disappointing given where the company says they are in moving the pipeline along.
The conclusion from an outsider looking in at this quarters insider buying activity would be either management has been good at convincing gullible shareholders to stick with the oncology potential, or management/BOD just missed potentially one of the last chances to invest at this level and make some serious money for themselves. It sure would have looked a whole lot better had insiders jumped in when they could have. I don't go for them needing to worry about taxes and being cash strapped and all that junk. We are too and so is anyone else buying shares. Insider buying shows belief in the positive elements of the strategy your management is telling everyone publicly. When little or no buying occurs prior to a potentially significant event, it shows a real lack of confidence from "insiders". Not at all a good look in my opinion.
Scioto1 wrote:
Does the company have the option to compensate board appointments with with stock and not cash?? When I looked at the the annual report looks like they make pretty good coin to serve on this board. Maybe there would be more incentive if it was paid in stock. Please advise.